Business

Business

Oil prices touch six week high as Strait of Hormuz is ‘completely closed’

Crude oil prices surged as Middle East conflict escalated on Thursday. Brent crude rose above $96 a barrel and WTI climbed past $88. Fresh attacks on oil tankers in the Red Sea fueled supply concerns. Iran’s Revolutionary Guards claimed control of the Strait of Hormuz. Houthi naval blockades further amplified worries over global energy shipments.

Read More
Business

Improving liquidity helping robust growth in credit: RBI

India’s economy shows resilience amid global uncertainties and fragile geopolitics. Liquidity conditions have improved, supporting robust credit growth across the nation. The external sector remains steady, with foreign investment inflows strengthening its outlook. Rural and urban demand conditions are healthy, reflecting strong economic activity. Retail inflation edged up in June, driven by food and fuel

Read More
Business

Temasek widens scope of India investments

Temasek is broadening its Indian investment focus beyond traditional sectors. The investor will now target industrials and artificial intelligence opportunities. Its India portfolio has grown significantly, reaching $42 billion by March 2026. The firm aims to double its recent capital deployment in the next three years. Temasek is increasing its AI exposure to fifteen percent

Read More
Business

‘Aam’ezing voyage: UP’s mangoes make first sea journey to Dubai

Indian mangoes reached Dubai via a 25-day sea journey. Nearly ninety percent of the fruit remained market-ready after transit. This successful shipment paves the way for cheaper and larger mango exports. The new protocol reduces reliance on expensive air freight for shipments. This development enhances farmer incomes and boosts export earnings.

Read More
Business

Trump’s 200% tariff plan may be a bitter pill for US consumers; Dr Reddy’s warns of costlier medicines

The United States plans significant tariffs on imported generic medicines. These duties will rise to 200% in the coming years. Dr Reddy’s Laboratories anticipates higher medicine prices for American consumers. Shifting manufacturing to the US is currently considered impractical by the company. India faces substantial exposure as a major generic medicine exporter to the US.

Read More